Literature DB >> 7082847

Radioimmunoassay of factor V in human plasma and platelets.

P B Tracy, L L Eide, E J Bowie, K G Mann.   

Abstract

Homogeneous, single-chain human factor V was used to develop a double antibody competition radioimmunoassay to measure factor V concentrations in plasma and platelets. Standard curves were constructed that allow for the detection of as little as 20 ng factor V/ml of plasma. Normal factor V concentrations range from 4 to 14 micrograms/ml of plasma with an average value of 7.0 +/- 2.0 micrograms/ml (n = 64). No correlation was observed between antigen levels and age or sex. The radioimmunoassay data are consistent with factor V clotting assays, providing freshly drawn plasma is used in the bioassay. Radioimmunoassay of washed platelets indicate that 0.63-1.93 microgram of factor V is present per 2.5 X 10(8) platelets (4612-14128 molecules of the factor V platelet). When normalized to individual hematocrits and platelet count, the data indicated that platelets contribute approximately 18%-25% of the factor V found in whole blood. In addition, two individuals with functionally deficient factor V were examined and found to be deficient in both antigen and activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082847

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  Coagulation procofactor activation by factor XIa.

Authors:  M F Whelihan; T Orfeo; M T Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-04       Impact factor: 5.824

2.  Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.

Authors:  Thomas J Cramer; John H Griffin; Andrew J Gale
Journal:  Pathophysiol Haemost Thromb       Date:  2010-05-22

3.  Isolated factor V deficiency in a patient with elevated PT and aPTT during routine pre-operative laboratory screening.

Authors:  Keyur Thakar; Kaushal Parikh; Yamei Chen; Delong Liu
Journal:  Stem Cell Investig       Date:  2014-02-08

4.  Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy.

Authors:  Dominik R Weiss; Gerd Juchem; Bernhard M Kemkes; Brigitte Gansera; Stephan Nees
Journal:  Int J Clin Exp Med       Date:  2009-05-28

5.  Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.

Authors:  Beth A Bouchard; John Chapin; Kathleen E Brummel-Ziedins; Peter Durda; Nigel S Key; Paula B Tracy
Journal:  Blood       Date:  2015-04-20       Impact factor: 22.113

6.  The role of thrombin exosites I and II in the activation of human coagulation factor V.

Authors:  Kenneth Segers; Björn Dahlbäck; Paul E Bock; Guido Tans; Jan Rosing; Gerry A F Nicolaes
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

7.  Location of the multimerin 1 binding site in coagulation factor V: an update.

Authors:  Samira B Jeimy; Mary Ann Quinn-Allen; Nola Fuller; William H Kane; Catherine P M Hayward
Journal:  Thromb Res       Date:  2008-05-02       Impact factor: 3.944

8.  Biosynthesis of factor V in isolated guinea pig megakaryocytes.

Authors:  H C Chiu; P K Schick; R W Colman
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

9.  Identification of four novel mutations in F5 associated with congenital factor V deficiency.

Authors:  Sachiko Kanaji; Taisuke Kanaji; Miho Honda; Sachie Nakazato; Kazuo Wakayama; Yoshitomi Tabata; Shoichiro Shibata; Hisashi Gondo; Ikuko Nakamura; Koichi Node; Masanori Miura; Masaharu Miyahara; Takashi Okamura; Fumio Nagumo; Shoichiro Ohta; Kenji Izuhara
Journal:  Int J Hematol       Date:  2008-12-04       Impact factor: 2.490

10.  Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.

Authors:  F Ayombil; S Abdalla; P B Tracy; B A Bouchard
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.